Acetylon Pharmaceuticals

Acetylon Pharmaceuticals (acetylon.com): 4 changes recorded in its website history since August 2009.

The website did not answer the latest live check. Last tried 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

New logosBetween 3 July 2014 and 10 July 2015
Added logos to its homepage: Multiple Myeloma Clinical Trials and Clinical_trials.
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation
HiringBetween 6 July 2011 and 3 August 2012
Added a careers page.
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation
FundingBetween 2 February 2011 and 6 July 2011
Announced on its homepage: “RECENT PRESS RELEASES Acetylon Pharmaceuticals Announces Completion of $27 Million Series B Round of Private Investor Financing HTML”.
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation
FundingBetween 9 August 2009 and 2 February 2011
Announced on its homepage: “PDF Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop Next-Generation Selective HDAC Inhibitors for Cancer and Rheumatoid…”.
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation

First recorded website

Observed 9 August 2009

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

Homepage

Funding statements on the website: Acetylon Contact Us Press Release Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop Next-Generation Selective HDAC Inhibitors for Cancer and Rheumatoid Arthritis August 7, 2009 HTML

archived page Link to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

Seen October 2025 · 1 capture · latest observed messagingGlobal Biopharmaceutical Company - Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
This wording observed 15 October 2025.
archived page
Seen July 2011 · 1 captureAcetylon Pharmaceuticals, Inc.
This wording observed 6 July 2011.
archived page

Summary of the record · AI-written

Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.

Acetylon Pharmaceuticals funding rounds and website updates

Acetylon Pharmaceuticals reported Series A and Series B financings, added a careers page, and later showed clinical trials-related logos on its homepage.

Between August 2009 and February 2011, Acetylon Pharmaceuticals announced on its homepage that it raised “$7.25 Million Series A” to develop next-generation selective HDAC inhibitors for cancer and rheumatoid indications. [1]
Between February 2011 and July 2011, Acetylon Pharmaceuticals announced on its homepage the completion of a “$27 Million Series B Round of Private Investor Financing”. [2]
Between July 2011 and August 2012, Acetylon Pharmaceuticals added a careers page to its website. [3]
Between July 2014 and July 2015, Acetylon Pharmaceuticals added Multiple Myeloma Clinical Trials and Clinical_trials logos to its homepage. [4]

Cite this record

StartupHistory, “Acetylon Pharmaceuticals” company record, https://startuphistory.org/c/acetylon.com

Machine-readable: /c/acetylon.com.json. How changes are found: method.